Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17533346 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL30714817 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL17533351 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL28361457 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL19086467 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL17533339 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL17533286 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL30714818 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL17533347 | 1.00 | EPHX1 (0.44) | EPHX1LMNARECQL | |
| SCHEMBL18272282 | 0.96 | EPHX1 (0.47) | EPHX1LMNARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10729666-B2 | Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament | HAISCO CHENGDU PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2020-08-04 | — | — | US | disclosed |
| CN-106278947-B | Crystal form of phenol derivative and preparation method thereof | 四川海思科制药有限公司 | 2020-03-06 | — | — | CN | disclosed |
| US-20170290781-A1 | USE OF GABAA RECEPTOR REINFORCING AGENT IN PREPARATION OF SEDATIVE AND ANESTHETIC MEDICAMENT | HAISCO INNOVATIVE PHARMACEUTICAL PTE. LTD. (SG) | 2017-10-12 | — | — | US | disclosed |
| US-20170290781-A1 | USE OF GABAA RECEPTOR REINFORCING AGENT IN PREPARATION OF SEDATIVE AND ANESTHETIC MEDICAMENT | HAISCO INNOVATIVE PHARMACEUTICAL PTE. LTD. (SG) | 2017-10-12 | — | — | US | disclosed |
| WO-2016026459-A1 | ISOPROPYL PHENOL DERIVATIVE AND PREPARATION METHOD THEREOF | 四川海思科制药有限公司 | 2016-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10729666-B2 | Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament | GABRA1, GABRA5, GABRA2 | EPHX1 2554/4885LMNA 4184/4885RECQL 3673/4885 |
| US-20170290781-A1 | USE OF GABAA RECEPTOR REINFORCING AGENT IN PREPARATION OF SEDATIVE AND ANESTHETIC MEDICAMENT | GABRA1, GABRA5, GABRA2 | EPHX1 2554/4885LMNA 4184/4885RECQL 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.